Warren Buffett makes big investment in US pharmaceutical firms

Berkshire Hathaway bought $5.7bn worth of shares in four companies in third quarter

The investment company run by billionaire investor Warren Buffett bet $5.7bn (£4.3bn) on pharmaceutical companies during the third quarter of 2020, as the sector takes centre stage in the fight against the coronavirus pandemic.

Berkshire Hathaway bought shares in drug companies AbbVie, Bristol-Myers Squibb, Merck and Pfizer between July and September, according to filings with the US regulator.

Share purchases by Buffett, known as the “Sage of Omaha”, are heavily scrutinised because of his long record of delivering strong returns for investors. That record has made the 90-year-old the world’s sixth richest person, with a net worth of $88bn, according to the Bloomberg Billionaires Index.

The investment company, which is based in Omaha, the largest city in Nebraska state, has struggled during the pandemic, with investments such as Buffett’s major bet on the US airline industry hit. Shares in Berkshire Hathaway have gained 3.7% during 2020, lagging behind the broad S&P 500 index of US stocks, which is up 12%.

Buffett’s bet on the US pharmaceutical industry is likely to be seen as another boost for the sector as it takes centre stage in the battle against the coronavirus pandemic. US pharmaceutical companies Pfizer and Moderna, the latter not among Berkshire Hathaway’s new investments, have published preliminary findings suggesting that their vaccines against Sars-CoV-2 are both more than 90% effective.

The vaccine news added further positive momentum to global stocks, which have defied the huge economic costs of lockdowns triggered by the pandemic to rise during the course of 2020.

Berkshire Hathaway’s stake in Pfizer was the smallest of its new pharma investments, with a value of $136m. The AbbVie and Merck stakes were each worth $1.9bn, while the Bristol-Myers-Squibb investment was worth $1.8bn at the end of September.

Other drug companies in Berkshire Hathaway’s portfolio include Biogen, Johnson & Johnson and Teva Pharmaceuticals.

Sign up to the daily Business Today email or follow Guardian Business on Twitter at @BusinessDesk

Its biggest single holding remained the tech company Apple. Berkshire reduced its stake in the iPhone manufacturer slightly during the quarter, but share price increases meant the value of its stake rose from $89.4bn to more than $109bn.

Among its other investments are online retail company Amazon, card payments companies Mastercard and Visa, as well as food and drink companies Kraft Heinz and Coca-Cola. Berkshire Hathaway also has a stake in Suncor Energy, one of the key players in the controversial exploitation of the Canadian tar sands.

The US banking sector is also a major part of Berkshire Hathaway’s portfolio, but the company sold some of its shares in JP Morgan Chase, M&T Bank, PNC Financial and Wells Fargo during the quarter. However, the investment company did add to its stake in Bank of America.

Contributor

Jasper Jolly

The GuardianTramp

Related Content

Buffett investment boosts GSK

Fresh from proposing a wheeze supposedly to help the troubled US monoline insurers, billionaire investor Warren Buffett has put some life into GlaxoSmithKline.

Nick Fletcher

15, Feb, 2008 @10:50 AM

Article image
Pharmaceutical firms’ shares tumble after US plans patent waiver on Covid vaccines
Experts say manufacturing bottlenecks and material shortages are bigger hurdle to making more vaccines

Julia Kollewe

06, May, 2021 @2:02 PM

Article image
Warren Buffett: cutting jobs is standard capitalist formula
US billionaire defends business methods of 3G, his partner in Kraft Heinz, which launched a failed bid for Unilever

Jill Treanor

08, May, 2017 @3:52 PM

Article image
Warren Buffett sparks succession talk with new hire
Todd Combs is joining the Berkshire Hathaway conglomerate in a move that puts him among the frontrunners to replace Buffett

Graeme Wearden

26, Oct, 2010 @9:26 AM

Article image
Warren Buffett: the sage of Omaha at bay | Dominic Rushe

Dominic Rushe: At this shareholders' meeting, Warren Buffett faces questions not only about his succession but over his backing for David Sokol

Dominic Rushe in Omaha, Nebraska

30, Apr, 2011 @3:00 PM

Article image
Warren Buffett takes swipe at Trump in shareholder letter
Investor wrote that ‘it is beyond arrogance for American businesses or individuals to boast that they have “done it alone”’

Edward Helmore in New York and agencies

23, Feb, 2019 @6:25 PM

Article image
Warren Buffett dumps US airline stocks, saying 'world has changed' after Covid-19
The legendary investor indicates that financial markets could still have further to fall as worldwide cases edge towards 3.5m

Martin Farrer

03, May, 2020 @5:03 AM

Article image
Apple value falls below $400bn, as Warren Buffett says 'ignore critics'

Tech company's stock price hit all-time high in September with $705.07 per share, but stocks now at 52-week low

Dominic Rushe in New York and Charles Arthur

04, Mar, 2013 @9:50 PM

Article image
Warren Buffett names Greg Abel as next CEO of Berkshire Hathaway
Billionaire, 90, lets slip plan for vice-chairman to take over at $644bn investment group

Edward Helmore in New York

03, May, 2021 @6:01 PM

Warren Buffett

Back in the mid-1990s when Warren Buffett, formerly the world's greatest investor, took a stake in Guinness (pre-Diageo) the excitement was quickly followed by gnashing of teeth when the shares proceeded to under-perform and the Sage of Omaha sold out.

15, Mar, 2000 @1:30 AM